Our Therapeutic Areas
The cornerstone of our research into new medicines is focused on those disease areas where we have built significant expertise over time. We are concentrating our research efforts and investment in these key therapeutic areas: CardioMetabolic diseases; Central Nervous System diseases; Immunology and Respiratory diseases; and Oncology and Cancer Immunology.
Oncology and Cancer Immunology Research
Our commitment to innovation in oncology research has resulted in the launch of two products for the treatment of non-small cell lung cancer. Our research strategy has two major focus areas: cancer cell-directed therapies and immune cell-directed therapies.
-
Cancer Immunology
Learn more about how we’re turning up the heat on cancer through our ‘cold’ tumor innovation approach.
-
Our Partners
Jon Weidanz, CSO, talks about re-imagining cancer immunotherapy and the essential ingredients for successful partnerships.
-
Therapeutic Areas
-
Cancer Immunology
-
Cancer Immunology
Dr. Jonathon Sedgwick, Head of Cancer Immunology and Immune Modulation at Boehringer Ingelheim, talks about how BI is turning up the heat on cancer
-
Cancer Immunology
-
Cancer Immunology
-
Cancer Immunology